iAMRapid delivers direct-from-blood, AI-driven Antimicrobial Susceptibility Testing (AST) with parallel pathogen ID in just a few hours. We give clinicians the critical results they need to fight sepsis and combat antimicrobial resistance—without waiting for culture growth.
Pre-seed startup founded in 2025
24+
HOURS
Blood Culture + AST Testing Time
In sepsis, every hour without the correct antibiotic
dramatically increases mortality risk.
Delayed testing contributes to inappropriate antibiotic use,
accelerating the AMR crisis.
Current antimicrobial susceptibility testing methods are
fundamentally limited by their reliance on bacterial culture growth.
Blood cultures take 6-12 hours, then AST adds another 8-12
hours.
This 24+ hour total delay leaves clinicians treating
critically ill sepsis patients with empiric therapy—essentially
educated guesses. Direct-from-blood AST is not just an
improvement—it's
essential for saving lives.
We are reimagining infection diagnostics from the ground up
Direct-from-Blood
No Culture Required
Our technology uses a direct-from-blood approach combined with AI-driven microfluidics. Our machine takes a blood sample and instantly splits it into two parallel lanes—eliminating the need for lengthy culture growth:
Instant identification of the infectious agent
Intelligent susceptibility testing with machine learning
This parallel process delivers faster, more reliable results in just a few hours, empowering clinicians to guide targeted therapy for critical sepsis cases and combat antimicrobial resistance effectively.
Sample (whole-blood)
Blood Culture + ID
⏱️ 6-12 hours
AST
⏱️ 8-12 hours
Result in 24+ Hours
Sequential Process = Slow
Sample Filtering
from Whole-Blood to Bacterial Suspension
Split into Two Parallel Lanes
Lane 1: Rapid ID
Lane 2: AI AST
Result in ~5 Hours
Parallel Processing = Speed
Get life-saving data to clinicians in just a few hours, dramatically faster than traditional methods—critical for sepsis treatment.
AI-powered, label-free analysis reveals low-frequency resistant subpopulations other tests miss.
Clinicians get earlier, more comprehensive, and more reliable susceptibility profiles.
We are a team of dedicated scientists, engineers, and designers passionate about solving one of medicine's greatest challenges.
Product and UX/UI Designer
Crafting intuitive interfaces that empower clinicians to make rapid, informed decisions.
PhD in Biomedical Engineering
Engineering innovative microfluidic solutions for rapid diagnostic testing.
PhD in Microbiology
Deep expertise in antimicrobial resistance and infectious disease diagnostics.
We're building a team of world-class scientists and engineers. If you're passionate about saving lives through innovation, we'd love to hear from you.
Get in TouchWe are actively seeking feedback, suggestions, and partners to help bring this life-saving technology that delivers results in around 5 hours to the clinic.
Whether you are a clinician, a researcher, a hospital administrator, or an institute, we want to hear from you.